Clinical Trial: Prospective Observational Study on Predictive Factors for the Onset and Severity of Cytokine Release Syndrome in Small Cell Lung Cancer Patients Treated with Tarlatamab (Japan)

Tokyo, July 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062128) titled 'Prospective Observational Study on Predictive Factors for the Onset and Severity of Cytokine Release Syndrome in Small Cell Lung Cancer Patients Treated with Tarlatamab' on July 2.

Study Type: Observational

Primary Sponsor: Institute - Kanagawa Cancer Center

Condition: Condition - small cell lung cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The aim of this study is to identify predictive factors associated with the onset and severity of cytokine release syndrome (CRS) in small cell lung cancer patients treated with tarlatamab. A comprehensive analysis...